Result update for NGL Fine Chem for Sep 15
Highlights:
YoY:
Revenue down 1% (YoY)
Operating profit (PBDT) up 26% (YoY)
Net profit/EPS up 12% (YoY)
QoQ
Revenue down 7% (QoQ)
Operating profit (PBDT) up 5% (QoQ)
Net profit/EPS up 8% (QoQ)
Change in shareholding pattern:
YoY: Promoters holding up 5% from 62.86% to 66.09%
QoQ: Promoters holding up 2% from 64.55% to 66.09%
Last 12 months eps is Rs 15.68 and current market price of Rs240 leading to PE of 15.3
Company is working in niche area of animal pharma. The stock is up almost 5 times in last 1 year. I am long past a decade now.
All in all its looks a good long term bet for me.
https://docs.google.com/spreadsheets/d/1EsA4D0Gr4ythn_V5J0WeKx4SktXnF5tWN26nChTaI1s/edit?usp=sharing
Registration status with SEBI: I am not registered with SEBI under the (Research Analyst) regulations 2014 and as per clarifications provided by SEBI: “Any person who makes recommendation or offers an opinion concerning securities or public offers only through public media is not required to obtain registration as research analyst under RA Regulations”
Disclosure: It is safe to assume that I might have the stock in my portfolio and hence my point of view can be biased. Readers should consult their financial advisory before any investments.
Highlights:
YoY:
Revenue down 1% (YoY)
Operating profit (PBDT) up 26% (YoY)
Net profit/EPS up 12% (YoY)
QoQ
Revenue down 7% (QoQ)
Operating profit (PBDT) up 5% (QoQ)
Net profit/EPS up 8% (QoQ)
Change in shareholding pattern:
YoY: Promoters holding up 5% from 62.86% to 66.09%
QoQ: Promoters holding up 2% from 64.55% to 66.09%
Last 12 months eps is Rs 15.68 and current market price of Rs240 leading to PE of 15.3
Company is working in niche area of animal pharma. The stock is up almost 5 times in last 1 year. I am long past a decade now.
All in all its looks a good long term bet for me.
https://docs.google.com/spreadsheets/d/1EsA4D0Gr4ythn_V5J0WeKx4SktXnF5tWN26nChTaI1s/edit?usp=sharing
Note: The above is not a research report but information as available on public domain and it should not be treated as a research report.
Registration status with SEBI: I am not registered with SEBI under the (Research Analyst) regulations 2014 and as per clarifications provided by SEBI: “Any person who makes recommendation or offers an opinion concerning securities or public offers only through public media is not required to obtain registration as research analyst under RA Regulations”
Disclosure: It is safe to assume that I might have the stock in my portfolio and hence my point of view can be biased. Readers should consult their financial advisory before any investments.
No comments:
Post a Comment